Results 141 to 150 of about 8,290,010 (315)

Modbury Hospital Annual Report 2001-2002

open access: yes, 2001
Modbury Hospital Annual Report for 2001 ...
Modbury Hospital
core  

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

open access: yesMolecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy   +10 more
wiley   +1 more source

Modbury Hospital Bed Race Winners photo

open access: yes, 1989
Colour photo with the winners of the 1989 Modbury Hospital Bed race - the ...
Modbury Hospital
core  

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Explaining Management Status of Intensive Care Units Beds: A Qualitative Study

open access: yesJournal of Qualitative Research in Health Sciences, 2019
Introduction: Access to intensive care unit (ICU) beds varies in different countries. Due to the population growth, aging, and longer survival of chronic patients, demand for these beds is increasing all over the world. The present study was performed to
Sima Marzban   +3 more
doaj  

Modbury Hospital Annual Report 1982-1983

open access: yes, 1982
The annual report for Modbury Hospital in the year 1982-1983.
Modbury Hospital
core  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Modbury Hospital 20th Anniversary Celebration Commemorative Booklet

open access: yes, 1992
Booklet containing information commemorating Modbury Hospital in its 20th ...
Modbury Hospital
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy